Top compounds associated with response to PARP15


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC -0.016 0.7
mRNA tosedostat CTRPv2 pan-cancer AAC 0.027 0.5
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.012 0.7
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.032 0.4
mRNA triptolide CTRPv2 pan-cancer AAC 0.021 0.6
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.094 0.07
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.038 0.3
mRNA valdecoxib CTRPv2 pan-cancer AAC -0.079 0.04
Download CSV